Trulieve Cannabis Corp banner
T

Trulieve Cannabis Corp
OTC:TCNNF

Watchlist Manager
Trulieve Cannabis Corp
OTC:TCNNF
Watchlist
Price: 6.22 USD -6.75% Market Closed
Market Cap: $1.2B

Relative Value

The Relative Value of one TCNNF stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.22 USD, Trulieve Cannabis Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TCNNF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

TCNNF Competitors Multiples
Trulieve Cannabis Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Trulieve Cannabis Corp
OTC:TCNNF
1.6B USD 1 -8.6 4.6 10.6
US
Eli Lilly and Co
NYSE:LLY
993.5B USD 15.2 48.1 32.4 34.5
US
Johnson & Johnson
NYSE:JNJ
590.8B USD 6.3 22 15.3 18.8
CH
Roche Holding AG
SIX:ROG
298B CHF 4.9 31.7 13.3 15.6
UK
AstraZeneca PLC
LSE:AZN
239.4B GBP 5.6 32.2 17.7 25
CH
Novartis AG
SIX:NOVN
246.7B CHF 5.6 22.7 14 18
US
Merck & Co Inc
NYSE:MRK
307.1B USD 4.7 16.8 10.5 12.3
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.5 10.5 7.8 9.2
US
Pfizer Inc
NYSE:PFE
153.9B USD 2.5 19.8 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
123.1B USD 2.6 17.5 7.3 9
P/E Multiple
Earnings Growth PEG
US
T
Trulieve Cannabis Corp
OTC:TCNNF
Average P/E: 24.6
Negative Multiple: -8.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22
7%
3.1
CH
Roche Holding AG
SIX:ROG
31.7
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
32.2
26%
1.2
CH
Novartis AG
SIX:NOVN
22.7
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.8
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.5
7%
1.5
US
Pfizer Inc
NYSE:PFE
19.8
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
Trulieve Cannabis Corp
OTC:TCNNF
Average EV/EBITDA: 42.1
4.6
11%
0.4
US
Eli Lilly and Co
NYSE:LLY
32.4
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.3
2%
7.6
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
17.7
11%
1.6
CH
Novartis AG
SIX:NOVN
14
9%
1.6
US
Merck & Co Inc
NYSE:MRK
10.5
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.8
7%
1.1
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.3
-12%
N/A